Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Immupharma (IMM) Regulatory News

Date Source Headline
11th Feb 2015 12:02 pm RNS CANCER UPDATE: IPP-204106
27th Jan 2015 7:00 am RNS Enterprise Investment Scheme Status
22nd Jan 2015 7:00 am RNS Collaboration Agreement with Simbec-Orion
30th Oct 2014 11:10 am RNS Holding(s) in Company
28th Oct 2014 7:00 am RNS Holding(s) in Company
21st Oct 2014 7:00 am RNS Additional Listing - Conditional Placing
20th Oct 2014 7:00 am RNS ImmuPharma awarded EUR400,000 Grant
30th Sep 2014 7:05 am RNS Half Yearly Report
30th Sep 2014 7:00 am RNS LupuzorT Gears Up To Start Pivotal Phase III trial
27th Jun 2014 1:11 pm RNS Result of AGM
27th Jun 2014 7:00 am RNS Access to pioneering research in Bordeaux France
16th Jun 2014 7:00 am RNS NEW NUCANT PATENTS
23rd May 2014 7:00 am RNS Annual Financial Report
21st May 2014 7:00 am RNS Preliminary Results
6th May 2014 12:47 pm RNS Dr. Sylviane Muller - Presentation Abstract
23rd Apr 2014 7:00 am RNS Dr. S Muller, founder of Lupuzor presentation.
11th Apr 2014 7:00 am RNS ImmuPharma Sponsors the 2014 European Lupus Confer
14th Oct 2013 7:00 am RNS Additional Listing
27th Sep 2013 7:00 am RNS Half Yearly Report
13th Aug 2013 7:00 am RNS UPDATE CANCER PROGRAMME IPP-204106
31st Jul 2013 7:00 am RNS FDA GRANTS IMMUPHARMA AMENDED SPA
8th Jul 2013 8:00 am RNS IMMUPHARMA APPOINTS WORLDWIDE KEY OPINION LEADERS
5th Jun 2013 7:00 am RNS Holding(s) in Company
23rd May 2013 12:29 pm RNS Result of AGM
21st May 2013 7:00 am RNS £50M Financing Facility - Darwin Strategic
22nd Apr 2013 7:00 am RNS Posting of Annual Report and AGM Notice
9th Apr 2013 7:00 am RNS Preliminary Results
28th Feb 2013 7:01 am RNS ImmuPharma Commences Trading on Stuttgart Exchange
28th Jan 2013 4:03 pm RNS Director/PDMR Shareholding - Replacement
28th Jan 2013 1:18 pm RNS Director/PDMR Shareholding
28th Jan 2013 9:33 am RNS CNRS Confirms Lupuzor's (TM) Effectiveness
15th Nov 2012 7:30 am RNS Lupuzor Presentation
5th Nov 2012 7:00 am RNS Lupuzor Presentation
3rd Oct 2012 7:00 am RNS Notification of Major Interest in Shares
26th Sep 2012 7:01 am RNS First Cancer Patients in New Trial Begin Dosing
26th Sep 2012 7:00 am RNS Interim Results
20th Sep 2012 7:00 am RNS Notification of Interim Results
7th Sep 2012 11:12 am RNS Rodman and Renshaw Conference
17th Aug 2012 9:11 am RNS Notification of Major Interest in Shares
11th Jul 2012 7:00 am RNS Voted Best Medical Research & Development Company
FTSE 100 Latest
Value9,513.40
Change29.82